Atherosclerotic Cardiovascular Disease (ASCVD) with Chronic Kidney Disease
When someone has atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD), it’s important to lower the risk of events such as heart attacks, strokes, and kidney function decline. These risks may be linked to obesity and changes in metabolism. Medications that target cardiometabolic markers, such as blood pressure, cholesterol, blood glucose, and body weight may also help improve cardiovascular and kidney outcomes. Research is needed for investigational medications that may improve ASCVD and CKD outcomes in patients who are overweight or obese.
To learn about clinical trials for ASCVD and CKD call our Fleming Island office:
(904) 621-0390
This research is enrolling at:
Fleming Island Center for Clinical Research
1679 Eagle Harbor Parkway
Suite D, 2nd Floor Fleming Island, FL 32003
(904) 621-0390
BELOW ARE HIDDEN ROWS
Fleming Island Center for Clinical Research
1679 Eagle Harbor Parkway
Suite D, 2nd Floor Fleming Island, FL 32003
(904) 621-0390
Jacksonville Center for Clinical Research
4085 University Blvd., South
Suite 1
Jacksonville, FL 32216
(904) 730-0166
St. Johns Center for Clinical Research
100 Whetstone Place,
Suites 300 – 301,
St. Augustine, FL 32086
(904) 209-0043
ENCORE Borland Groover Clinical Research
4800 Belfort Road, Suite 301
Jacksonville, FL 32256
(904) 680-0871
Nature Coast Clinical Research – Inverness
411 West Highland Boulevard
Inverness, FL 34452
(352) 341-2100
Nature Coast Clinical Research – Crystal River
6122 West Corporate Oaks Drive
Crystal River, FL 34429
(352) 861-1865
Learn More
If you want us to contact you about our research studies call (904) 730-0166 or sign up below!
Read the latest posts by our expert clinical staff!
- Category
- Fleming Island